Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Social Stream
Actinium Pharmaceuticals Inc (ATNM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ATNM.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 73 days, ATNM's average price target has gone down $0.
Over the past 73 days, ATNM's average upside potential has been 351.81%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATNM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 13 months, ATNM's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATNM as an investment opportunity.
- Actinium Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 97.52% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Actinium Pharmaceuticals Inc's number of analysts covering the stock is greater than 12.65% of them.
- In terms of how Actinium Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 75.25% of that group.
- ATNM has a lower variance in analysts' estimates than 27.89% of stocks in the small market cap category.
What is the outlook for ATNM? Use POWR Ratings for clearer insight into price direction.